Stock ACHV ACHIEVE LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
5.41 USD 0.00% Intraday chart for Achieve Life Sciences, Inc. +8.20% +31.31%
May. 13 Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating MT
May. 09 Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be presented at Society of General Internal Medicine Annual Meeting
AQ
Achieve Life Sciences : Society of General Internal Medicine (SGIM) Annual Meeting
PU
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
AQ
Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating
MT
Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024
Achieve Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
AQ
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
AQ
Achieve Life Sciences, Inc. Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
CI
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
AQ
JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target
MT
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
AQ
Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
AQ
Achieve Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
AQ
Achieve Life Sciences, Inc. Announces Data from Cytisinicline ORCA Program to Be Presented at the 2024 Society for Research on Nicotine and Tobacco Annual Meeting
CI
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACHV Stock
  4. News Achieve Life Sciences, Inc.